This cohort study investigates patterns of buprenorphine treatment retention among US youth aged 10 to 18 years from 2015 to 2021.
Clinical Practice Guidelines
Monday, December 23
Latest
- Antibiotic Shortage During a Public Health Crisis—The Perfect Storm
- Tenant Right-to-Counsel and Adverse Birth Outcomes in New York, New York
- Developmental Timing of Associations Among Parenting, Brain Architecture, and Mental Health
- Prenatal Cannabis Exposure and Executive Function and Aggressive Behavior at Age 5 Years
- Optimal Oxygen Levels for Preterm Infant Resuscitation—Reply
- Optimal Oxygen Levels for Preterm Infant Resuscitation
- Prenatal Cannabis Exposure—An Intergenerational Risk Marker for Neurodevelopment
- What Parents Should Know About Crying in Infants
- Day Care Attendance and Risk of Type 1 Diabetes
- JAMA Pediatrics
- Trends in Location of Death for Individuals With Pediatric Cancer
- The Child Tax Credit—Tax Policy as Health Policy
- Medicaid Accountable Care Organizations and Disparities in Pediatric Asthma Care
- Mild Traumatic Brain Injury and Criminal Charges and Convictions in Mid and Late Adolescence
- Pooled Analysis of Physical Activity, Sedentary Behavior, and Sleep Among Children From 33 Countries
- Addressing Severe Obesity in Adolescents While Reducing Weight Stigma
- Paternal Age and the Risk of Trisomy 21
- Accounting for Children in Accountable Care Organizations
- What Is Childhood Lymphoma?
- JAMA Pediatrics
- Intermittent Energy Restriction for Adolescents With Obesity
- Depression and Eating Disorders in Adolescents With Obesity
- Prioritizing Data Privacy and Security in Pediatric AI—Reply
- Prioritizing Data Privacy and Security in Pediatric AI
- Transgender Adolescent School Climate, Mental Health, and Adult Social Support
- Intimate Partner Violence and Parenting
- Paid Family Leave and Acute Respiratory Tract Infections
- JAMA Pediatrics
- Error in Abstract
- Error in Byline and End Matter
- Ultraprocessed Foods at Home and Children’s Attentional Bias Toward Those Foods
- Drug Repurposing Via the Best Pharmaceuticals for Children Act
- Maternal Obesity and Risk of Sudden Unexpected Infant Death
- Disparities in HPV Vaccination by Health Care Facility Type
- Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy—Reply
- Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
- Buprenorphine Treatment Retention Among Youth in the US
- Maternal Obesity and Sudden Unexpected Infant Death
- What Teens Should Know About Choosing Contraception
- JAMA Pediatrics
- Abortion Bans Harm Not Just Pregnant People—They Harm Newborns and Infants Too
- Error in Author Affiliation
- What Parents Need to Know About Autism Screening and Early Treatment
- First-Trimester COVID-19 Vaccination and Structural Birth Defects
- Further Considerations on Gender-Affirming Care—Reply
- Further Considerations on Gender-Affirming Care
- Further Considerations on Gender-Affirming Care
- Delivery Room Oxygen for Preterm Infants
- Hospital-Onset Bacteremia—Counting Them All
- JAMA Pediatrics
- Variations by State in Firearm Suicide Among US Children and Young Adults, 2016-2021
- What Parents Need to Know About Peanut Allergy